Definitive Contract HDTRA114C0035
Award Date 7/15/14
Potential Completion Date 7/10/18
Potential Value $1.8M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
New Orleans, LA 70118, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
33
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a definitive cost-no-fee contract award valued at $643,054.00 from the Defense Threat Reduction Agency (DTRA) to The Administrators of the Tulane Educational Fund, doing business as Tulane University. The award does not have a set-aside designation. Tulane University is a private, non-profit university located in New Orleans, Louisiana that has a history of providing research and development, professional services, and products to support federal agency missions. This contract award is...
- The Defense Threat Reduction Agency (DTRA) awarded Tulane University a definitive contract valued at $7.31M for the development of a conotoxin aerosol disease model. Awarded on March 24, 2022, with an ultimate completion date of May 23, 2027, this cost-plus-no-fee contract represents Tulane's continued contribution to DTRA's biological threat reduction initiatives. The contract stems from DTRA's Broad Agency Announcement soliciting innovative research and development projects focused on...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $9,705,349.83 Definitive Contract to The Administrators of the Tulane Educational Fund, doing business as Tulane University, a private non-profit university in New Orleans, Louisiana. This non-severable base period contract runs from September 30, 2018 to September 29, 2019, with a completion date of July 14, 2024. The contract has a Cost No Fee pricing type...
- This is a delivery order award to The Administrators Of Tulane Educational Fund, doing business as Tulane University, under the National Institute of Allergy and Infectious Diseases' (NIAID) Simian Vaccine Evaluation Units master contract. The $1,796,343 award is for a study titled "CONDUCT STUDY P217" with a period of performance through October 30, 2026. The contract does not have a set-aside designation. As a comprehensive research university, Tulane University has extensive...
- This definitive, firm-fixed-price federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Administrators Of Tulane Educational Fund, doing business as Tulane University, for the "Development of Saponin DMLT Adjuvant (SDA)." The contract has a ceiling value of $4,695,387.00 and a completion date of September 29, 2026. No set-aside designation was used. Tulane University is a private, non-profit research university with...
- This firm fixed price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to the Administrators of Tulane Educational Fund, the parent organization of Tulane University, a private research university in New Orleans, Louisiana. The $150,000 contract is for animal models of infectious diseases research, as part of NIAID's broader Animal Models of Infectious Diseases 2010-2017 master...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $16.5 million cost-no-fee definitive contract to The Administrators of Tulane Educational Fund, doing business as Tulane University, for novel mucosal vaccine approaches for pneumonia. The award, made on September 23, 2022, extends through March 6, 2027, and will be performed in New Orleans, Louisiana. This contract was not subject to a set-aside designation. The work responds to NIAID's Broad Agency Announcement seeking...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $645,369.00 delivery order to The Administrators of the Tulane Educational Fund, doing business as Tulane University, on August 5, 2019. The award, which is not set aside, is for the Conduct Study P209 under the Simian Vaccine Evaluation Units 2013-2020 master contract vehicle. Tulane University, a private non-profit university located in New...
- This federal contract award, valued at $22,632,164.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to The Administrators of Tulane Educational Fund, doing business as Tulane University. The contract is for the operation of the Cellular Immunology Core Laboratory (CICL) to conduct, analyze, develop, optimize, and validate cellular immunologic assays for infectious diseases like HIV, Simian Immunodeficiency Virus, and Mycobacterium tuberculosis. The contract has...
- This is a federal contract award to The Administrators Of Tulane Educational Fund, doing business as Tulane University, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency. The contract, valued at $3,675,463.09, is a delivery order under the Simian Vaccine Evaluation Units (SVEUS) major program. It does not have a set-aside designation. The contract supports NIAID's mission of advancing research to understand, prevent, and treat infectious diseases by...